Related Experiment Video
Updated: Jun 6, 2025
10:10
Transport Properties of Ibuprofen Encapsulated in Cyclodextrin Nanosponge Hydrogels: A Proton HR-MAS NMR Spectroscopy Study
Published on: August 15, 2016
10.2K
Enhancing Cannabinoid Bioavailability in Pain Management: The Role of Cyclodextrins
Adriana Ribeiro1, Rui Loureiro1, Helena Cabral-Marques1
1Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal.
Molecules (Basel, Switzerland)
|November 27, 2024
Summary
Cyclodextrins enhance cannabinoid solubility and bioavailability for chronic pain. This improves therapeutic efficacy and patient outcomes for pain management.
Area of Science:
- Pharmacology
- Drug Delivery
- Natural Products Chemistry
Background:
- Chronic pain affects billions globally, with limited treatment options and significant burdens.
- Cannabis-derived compounds (THC, CBD) show therapeutic potential but suffer from poor solubility and bioavailability.
- Cyclodextrins (CDs) can encapsulate hydrophobic molecules, improving drug solubility, stability, and delivery.
Purpose of the Study:
- To explore the formation of cyclodextrin inclusion complexes with cannabinoids and terpenes.
- To enhance the pharmacokinetic profiles and therapeutic efficacy of these natural compounds.
- To investigate the potential of CDs in optimizing cannabinoid formulations for chronic pain management.
Main Methods:
- Formation of cyclodextrin inclusion complexes with cannabinoids and terpenes (D-limonene, beta-caryophyllene, gamma-terpinene).
- Characterization of these complexes using various analytical techniques.
- Discussion of the mechanisms of action and potential therapeutic applications.
Main Results:
- Cyclodextrins successfully form inclusion complexes with cannabinoids and terpenes.
- Enhanced solubility and bioavailability of the encapsulated compounds are anticipated.
- Optimized formulations show promise for improved therapeutic efficacy.
Conclusions:
- Cyclodextrins offer a viable strategy to overcome solubility and bioavailability challenges of cannabinoids.
- CD-cannabinoid complexes hold significant potential for improving chronic pain management.
- Further research into innovative formulations and delivery systems is warranted.
Related Concept Videos
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
202
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
202
01:25Analgesia and Pain Management
513
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
513
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
163
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
163
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
225
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
225
01:22Drug Delivery: Miscellaneous Routes
328
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
328
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
183
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
183